FI122247B - Probioottinen valmiste koiran maha- ja suolistokanavassa ilmenevien häiriöiden ennaltaehkäisemiseksi tai hoitamiseksi - Google Patents

Probioottinen valmiste koiran maha- ja suolistokanavassa ilmenevien häiriöiden ennaltaehkäisemiseksi tai hoitamiseksi Download PDF

Info

Publication number: FI122247B
Authority: FI; Finland
Prior art keywords: calcium; lactobacillus; dog; ncimb; lactic acid
Prior art date: 2009-08-12

Application number

FI20095836A

Other languages

English (en)

Finnish (fi)

Swedish (sv)

Other versions

FI20095836L (fi

FI20095836A0 (fi

Inventor

Kalevi Heinonen

Hanna Lehmussola

Shea Beasley

Original Assignee

Vetcare Oy

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-08-12

Filing date

2009-08-12

Publication date

2011-10-31

2009-08-12 Application filed by Vetcare Oy filed Critical Vetcare Oy

2009-08-12 Publication of FI20095836A0 publication Critical patent/FI20095836A0/fi

2009-08-12 Priority to FI20095836A priority Critical patent/FI122247B/fi

2010-06-23 Priority to HUE10808015A priority patent/HUE046610T2/hu

2010-06-23 Priority to CA2770625A priority patent/CA2770625C/en

2010-06-23 Priority to EP10808015.1A priority patent/EP2464362B1/en

2010-06-23 Priority to DK10808015T priority patent/DK2464362T3/da

2010-06-23 Priority to US13/389,948 priority patent/US9095160B2/en

2010-06-23 Priority to SI201031960T priority patent/SI2464362T1/sl

2010-06-23 Priority to PCT/FI2010/050538 priority patent/WO2011018547A1/en

2010-06-23 Priority to LTEP10808015.1T priority patent/LT2464362T/lt

2010-06-23 Priority to PT108080151T priority patent/PT2464362T/pt

2010-06-23 Priority to HRP20192223TT priority patent/HRP20192223T1/hr

2010-06-23 Priority to ES10808015T priority patent/ES2759776T3/es

2010-06-23 Priority to PL10808015T priority patent/PL2464362T3/pl

2011-02-13 Publication of FI20095836L publication Critical patent/FI20095836L/fi

2011-10-31 Application granted granted Critical

2011-10-31 Publication of FI122247B publication Critical patent/FI122247B/fi

Links

238000002360 preparation method Methods 0.000 title claims description 107
241000282472 Canis lupus familiaris Species 0.000 title claims description 102
239000006041 probiotic Substances 0.000 title claims description 101
235000018291 probiotics Nutrition 0.000 title claims description 101
230000000529 probiotic effect Effects 0.000 title claims description 85
238000011282 treatment Methods 0.000 title claims description 25
208000018522 Gastrointestinal disease Diseases 0.000 title claims description 15
230000002265 prevention Effects 0.000 title claims description 14
210000001035 gastrointestinal tract Anatomy 0.000 claims description 47
235000013305 food Nutrition 0.000 claims description 44
241000186660 Lactobacillus Species 0.000 claims description 42
229940039696 lactobacillus Drugs 0.000 claims description 38
230000001580 bacterial effect Effects 0.000 claims description 35
235000013406 prebiotics Nutrition 0.000 claims description 31
239000011575 calcium Substances 0.000 claims description 30
229960005069 calcium Drugs 0.000 claims description 28
229910052791 calcium Inorganic materials 0.000 claims description 28
239000000047 product Substances 0.000 claims description 28
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 27
229920001542 oligosaccharide Polymers 0.000 claims description 24
230000000968 intestinal effect Effects 0.000 claims description 22
241000186840 Lactobacillus fermentum Species 0.000 claims description 21
238000000034 method Methods 0.000 claims description 21
239000000203 mixture Substances 0.000 claims description 20
239000012530 fluid Substances 0.000 claims description 19
229940012969 lactobacillus fermentum Drugs 0.000 claims description 17
239000000843 powder Substances 0.000 claims description 16
241000218588 Lactobacillus rhamnosus Species 0.000 claims description 15
VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 14
240000006024 Lactobacillus plantarum Species 0.000 claims description 14
210000003608 fece Anatomy 0.000 claims description 14
235000013965 Lactobacillus plantarum Nutrition 0.000 claims description 12
239000000969 carrier Substances 0.000 claims description 12
238000009472 formulation Methods 0.000 claims description 12
-1 kalciumdiglukonat Chemical compound 0.000 claims description 12
229940072205 lactobacillus plantarum Drugs 0.000 claims description 12
VSGNNIFQASZAOI-UHFFFAOYSA-L calcium acetate Chemical compound [Ca+2].CC([O-])=O.CC([O-])=O VSGNNIFQASZAOI-UHFFFAOYSA-L 0.000 claims description 11
239000001639 calcium acetate Substances 0.000 claims description 11
235000011092 calcium acetate Nutrition 0.000 claims description 11
229960005147 calcium acetate Drugs 0.000 claims description 11
235000013336 milk Nutrition 0.000 claims description 10
239000008267 milk Substances 0.000 claims description 10
210000004080 milk Anatomy 0.000 claims description 10
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
150000002482 oligosaccharides Chemical class 0.000 claims description 8
241000186869 Lactobacillus salivarius Species 0.000 claims description 7
241000192001 Pediococcus Species 0.000 claims description 7
235000015895 biscuits Nutrition 0.000 claims description 7
235000010216 calcium carbonate Nutrition 0.000 claims description 7
229910000019 calcium carbonate Inorganic materials 0.000 claims description 7
239000008188 pellet Substances 0.000 claims description 7
239000000546 pharmaceutical excipient Substances 0.000 claims description 7
239000002775 capsule Substances 0.000 claims description 6
241000394636 Lactobacillus mucosae Species 0.000 claims description 5
229960003563 calcium carbonate Drugs 0.000 claims description 5
239000003814 drug Substances 0.000 claims description 5
239000000796 flavoring agent Substances 0.000 claims description 5
235000015067 sauces Nutrition 0.000 claims description 5
239000000725 suspension Substances 0.000 claims description 5
235000007319 Avena orientalis Nutrition 0.000 claims description 4
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 4
235000010469 Glycine max Nutrition 0.000 claims description 4
229920001202 Inulin Polymers 0.000 claims description 4
229920002774 Maltodextrin Polymers 0.000 claims description 4
244000134552 Plantago ovata Species 0.000 claims description 4
235000003421 Plantago ovata Nutrition 0.000 claims description 4
239000009223 Psyllium Substances 0.000 claims description 4
241000202221 Weissella Species 0.000 claims description 4
230000002708 enhancing effect Effects 0.000 claims description 4
239000000945 filler Substances 0.000 claims description 4
239000000499 gel Substances 0.000 claims description 4
229940029339 inulin Drugs 0.000 claims description 4
JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims description 4
238000004519 manufacturing process Methods 0.000 claims description 4
230000008569 process Effects 0.000 claims description 4
229940070687 psyllium Drugs 0.000 claims description 4
235000013580 sausages Nutrition 0.000 claims description 4
244000075850 Avena orientalis Species 0.000 claims description 3
229920002498 Beta-glucan Polymers 0.000 claims description 3
102000011045 Chloride Channels Human genes 0.000 claims description 3
108010062745 Chloride Channels Proteins 0.000 claims description 3
239000004134 Dicalcium diphosphate Substances 0.000 claims description 3
RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical class OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 3
JUNWLZAGQLJVLR-UHFFFAOYSA-J calcium diphosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])(=O)OP([O-])([O-])=O JUNWLZAGQLJVLR-UHFFFAOYSA-J 0.000 claims description 3
235000019821 dicalcium diphosphate Nutrition 0.000 claims description 3
229910000393 dicalcium diphosphate Inorganic materials 0.000 claims description 3
239000000839 emulsion Substances 0.000 claims description 3
235000012041 food component Nutrition 0.000 claims description 3
239000005417 food ingredient Substances 0.000 claims description 3
235000021255 galacto-oligosaccharides Nutrition 0.000 claims description 3
150000003271 galactooligosaccharides Chemical class 0.000 claims description 3
239000007788 liquid Substances 0.000 claims description 3
239000007937 lozenge Substances 0.000 claims description 3
239000000825 pharmaceutical preparation Substances 0.000 claims description 3
239000006188 syrup Substances 0.000 claims description 3
235000020357 syrup Nutrition 0.000 claims description 3
239000003826 tablet Substances 0.000 claims description 3
HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims description 2
FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 claims description 2
KQMCGGGTJKNIMC-UHFFFAOYSA-N 2-hydroxy-3-propyl-2h-furan-5-one Chemical compound CCCC1=CC(=O)OC1O KQMCGGGTJKNIMC-UHFFFAOYSA-N 0.000 claims description 2
UBLAMKHIFZBBSS-UHFFFAOYSA-N 3-Methylbutyl pentanoate Chemical compound CCCCC(=O)OCCC(C)C UBLAMKHIFZBBSS-UHFFFAOYSA-N 0.000 claims description 2
SATHPVQTSSUFFW-UHFFFAOYSA-N 4-[6-[(3,5-dihydroxy-4-methoxyoxan-2-yl)oxymethyl]-3,5-dihydroxy-4-methoxyoxan-2-yl]oxy-2-(hydroxymethyl)-6-methyloxane-3,5-diol Chemical compound OC1C(OC)C(O)COC1OCC1C(O)C(OC)C(O)C(OC2C(C(CO)OC(C)C2O)O)O1 SATHPVQTSSUFFW-UHFFFAOYSA-N 0.000 claims description 2
PVXPPJIGRGXGCY-TZLCEDOOSA-N 6-O-alpha-D-glucopyranosyl-D-fructofuranose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)C(O)(CO)O1 PVXPPJIGRGXGCY-TZLCEDOOSA-N 0.000 claims description 2
GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 2
239000001904 Arabinogalactan Substances 0.000 claims description 2
229920000189 Arabinogalactan Polymers 0.000 claims description 2
241000219310 Beta vulgaris subsp. vulgaris Species 0.000 claims description 2
UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 2
240000008886 Ceratonia siliqua Species 0.000 claims description 2
235000013912 Ceratonia siliqua Nutrition 0.000 claims description 2
241000206575 Chondrus crispus Species 0.000 claims description 2
244000037364 Cinnamomum aromaticum Species 0.000 claims description 2
235000014489 Cinnamomum aromaticum Nutrition 0.000 claims description 2
229920000858 Cyclodextrin Polymers 0.000 claims description 2
GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 claims description 2
229920001353 Dextrin Polymers 0.000 claims description 2
239000004375 Dextrin Substances 0.000 claims description 2
229920002148 Gellan gum Polymers 0.000 claims description 2
244000068988 Glycine max Species 0.000 claims description 2
244000303040 Glycyrrhiza glabra Species 0.000 claims description 2
235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 2
229920002907 Guar gum Polymers 0.000 claims description 2
235000017443 Hedysarum boreale Nutrition 0.000 claims description 2
235000007858 Hedysarum occidentale Nutrition 0.000 claims description 2
AYRXSINWFIIFAE-SCLMCMATSA-N Isomaltose Natural products OC[C@H]1O[C@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)[C@@H](O)[C@@H](O)[C@@H]1O AYRXSINWFIIFAE-SCLMCMATSA-N 0.000 claims description 2
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 2
240000003183 Manihot esculenta Species 0.000 claims description 2
235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 claims description 2
235000010804 Maranta arundinacea Nutrition 0.000 claims description 2
239000004373 Pullulan Substances 0.000 claims description 2
229920001218 Pullulan Polymers 0.000 claims description 2
MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 claims description 2
229920000294 Resistant starch Polymers 0.000 claims description 2
239000001882 Soybean hemicellulose Substances 0.000 claims description 2
235000021536 Sugar beet Nutrition 0.000 claims description 2
240000004584 Tamarindus indica Species 0.000 claims description 2
235000004298 Tamarindus indica Nutrition 0.000 claims description 2
244000145580 Thalia geniculata Species 0.000 claims description 2
235000012419 Thalia geniculata Nutrition 0.000 claims description 2
229920001615 Tragacanth Polymers 0.000 claims description 2
HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims description 2
MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 claims description 2
240000008042 Zea mays Species 0.000 claims description 2
235000002017 Zea mays subsp mays Nutrition 0.000 claims description 2
HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims description 2
235000019312 arabinogalactan Nutrition 0.000 claims description 2
239000000305 astragalus gummifer gum Substances 0.000 claims description 2
235000010410 calcium alginate Nutrition 0.000 claims description 2
239000000648 calcium alginate Substances 0.000 claims description 2
229960002681 calcium alginate Drugs 0.000 claims description 2
235000010376 calcium ascorbate Nutrition 0.000 claims description 2
239000011692 calcium ascorbate Substances 0.000 claims description 2
229940047036 calcium ascorbate Drugs 0.000 claims description 2
239000001110 calcium chloride Substances 0.000 claims description 2
229910001628 calcium chloride Inorganic materials 0.000 claims description 2
235000011148 calcium chloride Nutrition 0.000 claims description 2
239000000279 calcium ferrocyanide Substances 0.000 claims description 2
235000012251 calcium ferrocyanide Nutrition 0.000 claims description 2
239000004227 calcium gluconate Substances 0.000 claims description 2
229960004494 calcium gluconate Drugs 0.000 claims description 2
235000013927 calcium gluconate Nutrition 0.000 claims description 2
BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 claims description 2
239000000292 calcium oxide Substances 0.000 claims description 2
ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 claims description 2
235000012255 calcium oxide Nutrition 0.000 claims description 2
MCFVRESNTICQSJ-RJNTXXOISA-L calcium sorbate Chemical compound [Ca+2].C\C=C\C=C\C([O-])=O.C\C=C\C=C\C([O-])=O MCFVRESNTICQSJ-RJNTXXOISA-L 0.000 claims description 2
239000004303 calcium sorbate Substances 0.000 claims description 2
235000010244 calcium sorbate Nutrition 0.000 claims description 2
GBAOBIBJACZTNA-UHFFFAOYSA-L calcium sulfite Chemical compound [Ca+2].[O-]S([O-])=O GBAOBIBJACZTNA-UHFFFAOYSA-L 0.000 claims description 2
235000010261 calcium sulphite Nutrition 0.000 claims description 2
BLORRZQTHNGFTI-ZZMNMWMASA-L calcium-L-ascorbate Chemical compound [Ca+2].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] BLORRZQTHNGFTI-ZZMNMWMASA-L 0.000 claims description 2
OKHHGHGGPDJQHR-YMOPUZKJSA-L calcium;(2s,3s,4s,5s,6r)-6-[(2r,3s,4r,5s,6r)-2-carboxy-6-[(2r,3s,4r,5s,6r)-2-carboxylato-4,5,6-trihydroxyoxan-3-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylate Chemical compound [Ca+2].O[C@@H]1[C@H](O)[C@H](O)O[C@@H](C([O-])=O)[C@H]1O[C@H]1[C@@H](O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@H](O2)C([O-])=O)O)[C@H](C(O)=O)O1 OKHHGHGGPDJQHR-YMOPUZKJSA-L 0.000 claims description 2
NEEHYRZPVYRGPP-UHFFFAOYSA-L calcium;2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Ca+2].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O NEEHYRZPVYRGPP-UHFFFAOYSA-L 0.000 claims description 2
229940097362 cyclodextrins Drugs 0.000 claims description 2
235000019425 dextrin Nutrition 0.000 claims description 2
IQDXNHZDRQHKEF-UHFFFAOYSA-N dialuminum;dicalcium;dioxido(oxo)silane Chemical compound [Al+3].[Al+3].[Ca+2].[Ca+2].[O-][Si]([O-])=O.[O-][Si]([O-])=O.[O-][Si]([O-])=O.[O-][Si]([O-])=O.[O-][Si]([O-])=O IQDXNHZDRQHKEF-UHFFFAOYSA-N 0.000 claims description 2
150000002016 disaccharides Chemical class 0.000 claims description 2
229940079593 drug Drugs 0.000 claims description 2
235000010492 gellan gum Nutrition 0.000 claims description 2
239000000216 gellan gum Substances 0.000 claims description 2
239000008103 glucose Substances 0.000 claims description 2
150000004676 glycans Polymers 0.000 claims description 2
239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 claims description 2
235000010417 guar gum Nutrition 0.000 claims description 2
239000000665 guar gum Substances 0.000 claims description 2
229960002154 guar gum Drugs 0.000 claims description 2
229920000591 gum Polymers 0.000 claims description 2
DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 claims description 2
BJHIKXHVCXFQLS-PQLUHFTBSA-N keto-D-tagatose Chemical compound OC[C@@H](O)[C@H](O)[C@H](O)C(=O)CO BJHIKXHVCXFQLS-PQLUHFTBSA-N 0.000 claims description 2
239000008101 lactose Substances 0.000 claims description 2
JCQLYHFGKNRPGE-FCVZTGTOSA-N lactulose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 JCQLYHFGKNRPGE-FCVZTGTOSA-N 0.000 claims description 2
229960000511 lactulose Drugs 0.000 claims description 2
PFCRQPBOOFTZGQ-UHFFFAOYSA-N lactulose keto form Natural products OCC(=O)C(O)C(C(O)CO)OC1OC(CO)C(O)C(O)C1O PFCRQPBOOFTZGQ-UHFFFAOYSA-N 0.000 claims description 2
229920005610 lignin Polymers 0.000 claims description 2
150000002772 monosaccharides Chemical class 0.000 claims description 2
235000010987 pectin Nutrition 0.000 claims description 2
239000001814 pectin Substances 0.000 claims description 2
229920001277 pectin Polymers 0.000 claims description 2
229940127557 pharmaceutical product Drugs 0.000 claims description 2
150000004804 polysaccharides Polymers 0.000 claims description 2
235000019423 pullulan Nutrition 0.000 claims description 2
MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 claims description 2
235000021254 resistant starch Nutrition 0.000 claims description 2
235000019317 soybean hemicellulose Nutrition 0.000 claims description 2
QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims description 2
229910000391 tricalcium phosphate Inorganic materials 0.000 claims description 2
229920001285 xanthan gum Polymers 0.000 claims description 2
235000010493 xanthan gum Nutrition 0.000 claims description 2
239000000230 xanthan gum Substances 0.000 claims description 2
229940082509 xanthan gum Drugs 0.000 claims description 2
229920001221 xylan Polymers 0.000 claims description 2
150000004823 xylans Chemical class 0.000 claims description 2
239000006071 cream Substances 0.000 claims 5
235000013339 cereals Nutrition 0.000 claims 3
235000019634 flavors Nutrition 0.000 claims 3
235000013324 preserved food Nutrition 0.000 claims 3
239000006187 pill Substances 0.000 claims 2
239000011265 semifinished product Substances 0.000 claims 2
244000215068 Acacia senegal Species 0.000 claims 1
239000004132 Calcium polyphosphate Substances 0.000 claims 1
229920000084 Gum arabic Polymers 0.000 claims 1
229920000569 Gum karaya Polymers 0.000 claims 1
JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 claims 1
CVBNMWXECPZOLM-UHFFFAOYSA-N Rhamnetin Natural products COc1cc(O)c2C(=O)C(=C(Oc2c1)c3ccc(O)c(O)c3O)O CVBNMWXECPZOLM-UHFFFAOYSA-N 0.000 claims 1
241000934878 Sterculia Species 0.000 claims 1
235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims 1
235000010489 acacia gum Nutrition 0.000 claims 1
239000000205 acacia gum Substances 0.000 claims 1
235000013894 calcium 5'-ribonucleotide Nutrition 0.000 claims 1
239000004196 calcium 5'-ribonucleotide Substances 0.000 claims 1
LVGQIQHJMRUCRM-UHFFFAOYSA-L calcium bisulfite Chemical compound [Ca+2].OS([O-])=O.OS([O-])=O LVGQIQHJMRUCRM-UHFFFAOYSA-L 0.000 claims 1
AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 claims 1
239000001201 calcium disodium ethylene diamine tetra-acetate Substances 0.000 claims 1
235000011188 calcium disodium ethylene diamine tetraacetate Nutrition 0.000 claims 1
235000010260 calcium hydrogen sulphite Nutrition 0.000 claims 1
239000000920 calcium hydroxide Substances 0.000 claims 1
229910001861 calcium hydroxide Inorganic materials 0.000 claims 1
235000011116 calcium hydroxide Nutrition 0.000 claims 1
239000001362 calcium malate Substances 0.000 claims 1
OLOZVPHKXALCRI-UHFFFAOYSA-L calcium malate Chemical compound [Ca+2].[O-]C(=O)C(O)CC([O-])=O OLOZVPHKXALCRI-UHFFFAOYSA-L 0.000 claims 1
229940016114 calcium malate Drugs 0.000 claims 1
235000011038 calcium malates Nutrition 0.000 claims 1
235000019827 calcium polyphosphate Nutrition 0.000 claims 1
235000010957 calcium stearoyl-2-lactylate Nutrition 0.000 claims 1
239000003916 calcium stearoyl-2-lactylate Substances 0.000 claims 1
OEUVSBXAMBLPES-UHFFFAOYSA-L calcium stearoyl-2-lactylate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC(=O)OC(C)C(=O)OC(C)C([O-])=O.CCCCCCCCCCCCCCCCCC(=O)OC(C)C(=O)OC(C)C([O-])=O OEUVSBXAMBLPES-UHFFFAOYSA-L 0.000 claims 1
GUPPESBEIQALOS-UHFFFAOYSA-L calcium tartrate Chemical compound [Ca+2].[O-]C(=O)C(O)C(O)C([O-])=O GUPPESBEIQALOS-UHFFFAOYSA-L 0.000 claims 1
235000011035 calcium tartrate Nutrition 0.000 claims 1
239000001427 calcium tartrate Substances 0.000 claims 1
SHWNNYZBHZIQQV-UHFFFAOYSA-L calcium;disodium;2-[2-[bis(carboxylatomethyl)azaniumyl]ethyl-(carboxylatomethyl)azaniumyl]acetate Chemical compound [Na+].[Na+].[Ca+2].[O-]C(=O)C[NH+](CC([O-])=O)CC[NH+](CC([O-])=O)CC([O-])=O SHWNNYZBHZIQQV-UHFFFAOYSA-L 0.000 claims 1
239000011162 core material Substances 0.000 claims 1
235000005822 corn Nutrition 0.000 claims 1
235000010494 karaya gum Nutrition 0.000 claims 1
239000000231 karaya gum Substances 0.000 claims 1
229940039371 karaya gum Drugs 0.000 claims 1
235000010421 processed eucheuma seaweed Nutrition 0.000 claims 1
239000000640 processed eucheuma seaweed Substances 0.000 claims 1
239000000758 substrate Substances 0.000 claims 1
JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 103
241000894006 Bacteria Species 0.000 description 52
235000014655 lactic acid Nutrition 0.000 description 52
239000004310 lactic acid Substances 0.000 description 51
241000282465 Canis Species 0.000 description 32
206010012735 Diarrhoea Diseases 0.000 description 22
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 19
208000035475 disorder Diseases 0.000 description 15
230000012010 growth Effects 0.000 description 13
238000000855 fermentation Methods 0.000 description 12
230000004151 fermentation Effects 0.000 description 12
239000003795 chemical substances by application Substances 0.000 description 11
210000000936 intestine Anatomy 0.000 description 11
230000009286 beneficial effect Effects 0.000 description 10
230000008901 benefit Effects 0.000 description 8
210000004027 cell Anatomy 0.000 description 8
230000000694 effects Effects 0.000 description 8
241000186604 Lactobacillus reuteri Species 0.000 description 7
230000036541 health Effects 0.000 description 7
230000000813 microbial effect Effects 0.000 description 7
241000282326 Felis catus Species 0.000 description 6
241001465754 Metazoa Species 0.000 description 6
239000003242 anti bacterial agent Substances 0.000 description 6
230000003115 biocidal effect Effects 0.000 description 6
210000000987 immune system Anatomy 0.000 description 6
229940001882 lactobacillus reuteri Drugs 0.000 description 6
244000052769 pathogen Species 0.000 description 6
208000024891 symptom Diseases 0.000 description 6
206010020751 Hypersensitivity Diseases 0.000 description 5
208000022559 Inflammatory bowel disease Diseases 0.000 description 5
230000007815 allergy Effects 0.000 description 5
229940088710 antibiotic agent Drugs 0.000 description 5
239000001963 growth medium Substances 0.000 description 5
239000004615 ingredient Substances 0.000 description 5
235000011888 snacks Nutrition 0.000 description 5
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
229920002472 Starch Polymers 0.000 description 4
230000000845 anti-microbial effect Effects 0.000 description 4
150000001720 carbohydrates Chemical class 0.000 description 4
235000014633 carbohydrates Nutrition 0.000 description 4
201000010099 disease Diseases 0.000 description 4
238000004108 freeze drying Methods 0.000 description 4
208000015181 infectious disease Diseases 0.000 description 4
239000002609 medium Substances 0.000 description 4
230000001717 pathogenic effect Effects 0.000 description 4
108090000623 proteins and genes Proteins 0.000 description 4
239000008107 starch Substances 0.000 description 4
235000019698 starch Nutrition 0.000 description 4
230000035882 stress Effects 0.000 description 4
208000035143 Bacterial infection Diseases 0.000 description 3
241000186000 Bifidobacterium Species 0.000 description 3
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
208000036142 Viral infection Diseases 0.000 description 3
241000186675 Weissella confusa Species 0.000 description 3
238000010521 absorption reaction Methods 0.000 description 3
230000032683 aging Effects 0.000 description 3
238000013019 agitation Methods 0.000 description 3
208000022362 bacterial infectious disease Diseases 0.000 description 3
230000001684 chronic effect Effects 0.000 description 3
230000003247 decreasing effect Effects 0.000 description 3
235000005911 diet Nutrition 0.000 description 3
230000037213 diet Effects 0.000 description 3
239000000284 extract Substances 0.000 description 3
230000002496 gastric effect Effects 0.000 description 3
230000001976 improved effect Effects 0.000 description 3
230000000670 limiting effect Effects 0.000 description 3
230000007246 mechanism Effects 0.000 description 3
238000002156 mixing Methods 0.000 description 3
239000006072 paste Substances 0.000 description 3
235000018102 proteins Nutrition 0.000 description 3
102000004169 proteins and genes Human genes 0.000 description 3
210000000813 small intestine Anatomy 0.000 description 3
238000012360 testing method Methods 0.000 description 3
238000002560 therapeutic procedure Methods 0.000 description 3
210000001635 urinary tract Anatomy 0.000 description 3
GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
208000023275 Autoimmune disease Diseases 0.000 description 2
241000131482 Bifidobacterium sp. Species 0.000 description 2
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
229930186147 Cephalosporin Natural products 0.000 description 2
208000017667 Chronic Disease Diseases 0.000 description 2
241000193468 Clostridium perfringens Species 0.000 description 2
241000194033 Enterococcus Species 0.000 description 2
208000004262 Food Hypersensitivity Diseases 0.000 description 2
206010016946 Food allergy Diseases 0.000 description 2
206010017943 Gastrointestinal conditions Diseases 0.000 description 2
241000282412 Homo Species 0.000 description 2
241000282414 Homo sapiens Species 0.000 description 2
206010061218 Inflammation Diseases 0.000 description 2
240000001046 Lactobacillus acidophilus Species 0.000 description 2
241000186712 Lactobacillus animalis Species 0.000 description 2
244000199866 Lactobacillus casei Species 0.000 description 2
241001468157 Lactobacillus johnsonii Species 0.000 description 2
241000186610 Lactobacillus sp. Species 0.000 description 2
239000005913 Maltodextrin Substances 0.000 description 2
206010028980 Neoplasm Diseases 0.000 description 2
108091005804 Peptidases Proteins 0.000 description 2
239000001888 Peptone Substances 0.000 description 2
108010080698 Peptones Proteins 0.000 description 2
239000004365 Protease Substances 0.000 description 2
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
239000002253 acid Substances 0.000 description 2
239000000654 additive Substances 0.000 description 2
239000002518 antifoaming agent Substances 0.000 description 2
238000013459 approach Methods 0.000 description 2
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
230000037396 body weight Effects 0.000 description 2
239000000378 calcium silicate Substances 0.000 description 2
229910052918 calcium silicate Inorganic materials 0.000 description 2
235000012241 calcium silicate Nutrition 0.000 description 2
OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 2
XFWJKVMFIVXPKK-UHFFFAOYSA-N calcium;oxido(oxo)alumane Chemical compound [Ca+2].[O-][Al]=O.[O-][Al]=O XFWJKVMFIVXPKK-UHFFFAOYSA-N 0.000 description 2
201000011510 cancer Diseases 0.000 description 2
229940041514 candida albicans extract Drugs 0.000 description 2
229910052799 carbon Inorganic materials 0.000 description 2
238000005119 centrifugation Methods 0.000 description 2
229940124587 cephalosporin Drugs 0.000 description 2
150000001780 cephalosporins Chemical class 0.000 description 2
239000008121 dextrose Substances 0.000 description 2
206010012601 diabetes mellitus Diseases 0.000 description 2
238000003745 diagnosis Methods 0.000 description 2
FSBVERYRVPGNGG-UHFFFAOYSA-N dimagnesium dioxido-bis[[oxido(oxo)silyl]oxy]silane hydrate Chemical compound O.[Mg+2].[Mg+2].[O-][Si](=O)O[Si]([O-])([O-])O[Si]([O-])=O FSBVERYRVPGNGG-UHFFFAOYSA-N 0.000 description 2
238000001035 drying Methods 0.000 description 2
208000037902 enteropathy Diseases 0.000 description 2
235000021001 fermented dairy product Nutrition 0.000 description 2
238000001914 filtration Methods 0.000 description 2
239000013020 final formulation Substances 0.000 description 2
239000012467 final product Substances 0.000 description 2
235000020932 food allergy Nutrition 0.000 description 2
235000013355 food flavoring agent Nutrition 0.000 description 2
230000037406 food intake Effects 0.000 description 2
239000008187 granular material Substances 0.000 description 2
230000007366 host health Effects 0.000 description 2
230000028993 immune response Effects 0.000 description 2
230000004054 inflammatory process Effects 0.000 description 2
229910052500 inorganic mineral Inorganic materials 0.000 description 2
230000003993 interaction Effects 0.000 description 2
208000028774 intestinal disease Diseases 0.000 description 2
238000002955 isolation Methods 0.000 description 2
238000009533 lab test Methods 0.000 description 2
208000019423 liver disease Diseases 0.000 description 2
150000004668 long chain fatty acids Chemical class 0.000 description 2
239000000391 magnesium silicate Substances 0.000 description 2
229940035034 maltodextrin Drugs 0.000 description 2
239000000463 material Substances 0.000 description 2
235000013372 meat Nutrition 0.000 description 2
235000013384 milk substitute Nutrition 0.000 description 2
235000010755 mineral Nutrition 0.000 description 2
239000011707 mineral Substances 0.000 description 2
229910052757 nitrogen Inorganic materials 0.000 description 2
239000001301 oxygen Substances 0.000 description 2
229910052760 oxygen Inorganic materials 0.000 description 2
235000019319 peptone Nutrition 0.000 description 2
239000003755 preservative agent Substances 0.000 description 2
230000001737 promoting effect Effects 0.000 description 2
238000011321 prophylaxis Methods 0.000 description 2
230000002829 reductive effect Effects 0.000 description 2
241000894007 species Species 0.000 description 2
230000004083 survival effect Effects 0.000 description 2
208000011580 syndromic disease Diseases 0.000 description 2
210000001215 vagina Anatomy 0.000 description 2
230000003612 virological effect Effects 0.000 description 2
230000004580 weight loss Effects 0.000 description 2
239000012138 yeast extract Substances 0.000 description 2
XDIYNQZUNSSENW-UUBOPVPUSA-N (2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanal Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O XDIYNQZUNSSENW-UUBOPVPUSA-N 0.000 description 1
OMDQUFIYNPYJFM-XKDAHURESA-N (2r,3r,4s,5r,6s)-2-(hydroxymethyl)-6-[[(2r,3s,4r,5s,6r)-4,5,6-trihydroxy-3-[(2s,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methoxy]oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@H](O)[C@H](O)O1 OMDQUFIYNPYJFM-XKDAHURESA-N 0.000 description 1
HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 1
BDKLKNJTMLIAFE-UHFFFAOYSA-N 2-(3-fluorophenyl)-1,3-oxazole-4-carbaldehyde Chemical compound FC1=CC=CC(C=2OC=C(C=O)N=2)=C1 BDKLKNJTMLIAFE-UHFFFAOYSA-N 0.000 description 1
208000010444 Acidosis Diseases 0.000 description 1
206010001367 Adrenal insufficiency Diseases 0.000 description 1
229920001817 Agar Polymers 0.000 description 1
208000024827 Alzheimer disease Diseases 0.000 description 1
102000044503 Antimicrobial Peptides Human genes 0.000 description 1
108700042778 Antimicrobial Peptides Proteins 0.000 description 1
206010003011 Appendicitis Diseases 0.000 description 1
206010003645 Atopy Diseases 0.000 description 1
206010003694 Atrophy Diseases 0.000 description 1
241000209763 Avena sativa Species 0.000 description 1
235000007558 Avena sp Nutrition 0.000 description 1
241000271566 Aves Species 0.000 description 1
108010023063 Bacto-peptone Proteins 0.000 description 1
241000283690 Bos taurus Species 0.000 description 1
CBOCVOKPQGJKKJ-UHFFFAOYSA-L Calcium formate Chemical compound [Ca+2].[O-]C=O.[O-]C=O CBOCVOKPQGJKKJ-UHFFFAOYSA-L 0.000 description 1
241000283707 Capra Species 0.000 description 1
BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
206010009900 Colitis ulcerative Diseases 0.000 description 1
241000195493 Cryptophyta Species 0.000 description 1
102000004127 Cytokines Human genes 0.000 description 1
108090000695 Cytokines Proteins 0.000 description 1
ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
208000035240 Disease Resistance Diseases 0.000 description 1
241000196324 Embryophyta Species 0.000 description 1
208000017701 Endocrine disease Diseases 0.000 description 1
241000194031 Enterococcus faecium Species 0.000 description 1
241001495410 Enterococcus sp. Species 0.000 description 1
241000283086 Equidae Species 0.000 description 1
241001428166 Eucheuma Species 0.000 description 1
206010016654 Fibrosis Diseases 0.000 description 1
241000192125 Firmicutes Species 0.000 description 1
206010017533 Fungal infection Diseases 0.000 description 1
241000233866 Fungi Species 0.000 description 1
229920000926 Galactomannan Polymers 0.000 description 1
208000007882 Gastritis Diseases 0.000 description 1
208000005577 Gastroenteritis Diseases 0.000 description 1
108010010803 Gelatin Proteins 0.000 description 1
240000005979 Hordeum vulgare Species 0.000 description 1
235000007340 Hordeum vulgare Nutrition 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
206010061598 Immunodeficiency Diseases 0.000 description 1
208000029462 Immunodeficiency disease Diseases 0.000 description 1
206010022489 Insulin Resistance Diseases 0.000 description 1
208000005016 Intestinal Neoplasms Diseases 0.000 description 1
206010022678 Intestinal infections Diseases 0.000 description 1
241000186717 Lactobacillus acetotolerans Species 0.000 description 1
241000186716 Lactobacillus agilis Species 0.000 description 1
241000186715 Lactobacillus alimentarius Species 0.000 description 1
241000186723 Lactobacillus bifermentans Species 0.000 description 1
240000001929 Lactobacillus brevis Species 0.000 description 1
241000186679 Lactobacillus buchneri Species 0.000 description 1
241000218492 Lactobacillus crispatus Species 0.000 description 1
241000861211 Lactobacillus crustorum Species 0.000 description 1
241001134659 Lactobacillus curvatus Species 0.000 description 1
241000186673 Lactobacillus delbrueckii Species 0.000 description 1
241000509544 Lactobacillus gallinarum Species 0.000 description 1
241000186606 Lactobacillus gasseri Species 0.000 description 1
241000316283 Lactobacillus gastricus Species 0.000 description 1
240000002605 Lactobacillus helveticus Species 0.000 description 1
241001640457 Lactobacillus intestinalis Species 0.000 description 1
241001561398 Lactobacillus jensenii Species 0.000 description 1
241001468191 Lactobacillus kefiri Species 0.000 description 1
241001134654 Lactobacillus leichmannii Species 0.000 description 1
241000186871 Lactobacillus murinus Species 0.000 description 1
241001150383 Lactobacillus oligofermentans Species 0.000 description 1
241001643453 Lactobacillus parabuchneri Species 0.000 description 1
241000186605 Lactobacillus paracasei Species 0.000 description 1
241001643449 Lactobacillus parakefiri Species 0.000 description 1
241000866650 Lactobacillus paraplantarum Species 0.000 description 1
241000186684 Lactobacillus pentosus Species 0.000 description 1
241000692139 Lactobacillus rennini Species 0.000 description 1
241001438705 Lactobacillus rogosae Species 0.000 description 1
241000186870 Lactobacillus ruminis Species 0.000 description 1
241000186867 Lactobacillus sharpeae Species 0.000 description 1
241000316280 Lactobacillus ultunensis Species 0.000 description 1
241000751212 Lactobacillus vaccinostercus Species 0.000 description 1
241000186783 Lactobacillus vaginalis Species 0.000 description 1
241000577554 Lactobacillus zeae Species 0.000 description 1
241000110060 Lactobacillus zymae Species 0.000 description 1
241000194036 Lactococcus Species 0.000 description 1
240000007472 Leucaena leucocephala Species 0.000 description 1
235000010643 Leucaena leucocephala Nutrition 0.000 description 1
241000192132 Leuconostoc Species 0.000 description 1
206010025210 Lymphangiectasia Diseases 0.000 description 1
208000007532 Lymphangiectasis Diseases 0.000 description 1
241000124008 Mammalia Species 0.000 description 1
241000282346 Meles meles Species 0.000 description 1
241000736262 Microbiota Species 0.000 description 1
241000699670 Mus sp. Species 0.000 description 1
235000003805 Musa ABB Group Nutrition 0.000 description 1
240000008790 Musa x paradisiaca Species 0.000 description 1
208000031888 Mycoses Diseases 0.000 description 1
206010067482 No adverse event Diseases 0.000 description 1
208000001132 Osteoporosis Diseases 0.000 description 1
208000005141 Otitis Diseases 0.000 description 1
241001494479 Pecora Species 0.000 description 1
102000035195 Peptidases Human genes 0.000 description 1
235000015266 Plantago major Nutrition 0.000 description 1
239000004743 Polypropylene Substances 0.000 description 1
206010037660 Pyrexia Diseases 0.000 description 1
208000001647 Renal Insufficiency Diseases 0.000 description 1
102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
206010039163 Right ventricular failure Diseases 0.000 description 1
240000004808 Saccharomyces cerevisiae Species 0.000 description 1
206010040047 Sepsis Diseases 0.000 description 1
206010071061 Small intestinal bacterial overgrowth Diseases 0.000 description 1
235000019764 Soybean Meal Nutrition 0.000 description 1
UQZIYBXSHAGNOE-USOSMYMVSA-N Stachyose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO[C@@H]2[C@@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O2)O1 UQZIYBXSHAGNOE-USOSMYMVSA-N 0.000 description 1
241000194017 Streptococcus Species 0.000 description 1
206010042209 Stress Diseases 0.000 description 1
229930006000 Sucrose Natural products 0.000 description 1
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
241000282887 Suidae Species 0.000 description 1
210000001744 T-lymphocyte Anatomy 0.000 description 1
239000004098 Tetracycline Substances 0.000 description 1
208000025865 Ulcer Diseases 0.000 description 1
201000006704 Ulcerative Colitis Diseases 0.000 description 1
208000025609 Urogenital disease Diseases 0.000 description 1
206010046914 Vaginal infection Diseases 0.000 description 1
108010059993 Vancomycin Proteins 0.000 description 1
206010047115 Vasculitis Diseases 0.000 description 1
229930003268 Vitamin C Natural products 0.000 description 1
229930003427 Vitamin E Natural products 0.000 description 1
241000975185 Weissella cibaria Species 0.000 description 1
239000005862 Whey Substances 0.000 description 1
102000007544 Whey Proteins Human genes 0.000 description 1
108010046377 Whey Proteins Proteins 0.000 description 1
235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
230000002378 acidificating effect Effects 0.000 description 1
208000026545 acidosis disease Diseases 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
230000000996 additive effect Effects 0.000 description 1
210000000577 adipose tissue Anatomy 0.000 description 1
239000002671 adjuvant Substances 0.000 description 1
208000017515 adrenocortical insufficiency Diseases 0.000 description 1
238000005273 aeration Methods 0.000 description 1
239000008272 agar Substances 0.000 description 1
230000036626 alertness Effects 0.000 description 1
OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
208000026935 allergic disease Diseases 0.000 description 1
230000004075 alteration Effects 0.000 description 1
DNEHKUCSURWDGO-UHFFFAOYSA-N aluminum sodium Chemical compound [Na].[Al] DNEHKUCSURWDGO-UHFFFAOYSA-N 0.000 description 1
SXQXMCWCWVCFPC-UHFFFAOYSA-N aluminum;potassium;dioxido(oxo)silane Chemical compound [Al+3].[K+].[O-][Si]([O-])=O.[O-][Si]([O-])=O SXQXMCWCWVCFPC-UHFFFAOYSA-N 0.000 description 1
229960003022 amoxicillin Drugs 0.000 description 1
LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 description 1
208000007502 anemia Diseases 0.000 description 1
208000022531 anorexia Diseases 0.000 description 1
230000008485 antagonism Effects 0.000 description 1
230000003110 anti-inflammatory effect Effects 0.000 description 1
239000004599 antimicrobial Substances 0.000 description 1
239000003963 antioxidant agent Substances 0.000 description 1
230000003078 antioxidant effect Effects 0.000 description 1
235000006708 antioxidants Nutrition 0.000 description 1
206010003246 arthritis Diseases 0.000 description 1
208000006673 asthma Diseases 0.000 description 1
230000037444 atrophy Effects 0.000 description 1
235000013734 beta-carotene Nutrition 0.000 description 1
239000011648 beta-carotene Substances 0.000 description 1
TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
229960002747 betacarotene Drugs 0.000 description 1
210000000941 bile Anatomy 0.000 description 1
239000003613 bile acid Substances 0.000 description 1
239000003833 bile salt Substances 0.000 description 1
229940093761 bile salts Drugs 0.000 description 1
239000011230 binding agent Substances 0.000 description 1
230000004071 biological effect Effects 0.000 description 1
230000033228 biological regulation Effects 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
230000023555 blood coagulation Effects 0.000 description 1
239000000404 calcium aluminium silicate Substances 0.000 description 1
235000012215 calcium aluminium silicate Nutrition 0.000 description 1
229940078583 calcium aluminosilicate Drugs 0.000 description 1
WNCYAPRTYDMSFP-UHFFFAOYSA-N calcium aluminosilicate Chemical compound [Al+3].[Al+3].[Ca+2].[O-][Si]([O-])=O.[O-][Si]([O-])=O.[O-][Si]([O-])=O.[O-][Si]([O-])=O WNCYAPRTYDMSFP-UHFFFAOYSA-N 0.000 description 1
FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 description 1
239000001354 calcium citrate Substances 0.000 description 1
235000019255 calcium formate Nutrition 0.000 description 1
239000004281 calcium formate Substances 0.000 description 1
229940044172 calcium formate Drugs 0.000 description 1
NEEHYRZPVYRGPP-IYEMJOQQSA-L calcium gluconate Chemical compound [Ca+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O NEEHYRZPVYRGPP-IYEMJOQQSA-L 0.000 description 1
FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 description 1
239000001527 calcium lactate Substances 0.000 description 1
235000011086 calcium lactate Nutrition 0.000 description 1
229960002401 calcium lactate Drugs 0.000 description 1
ZCCIPPOKBCJFDN-UHFFFAOYSA-N calcium nitrate Chemical compound [Ca+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O ZCCIPPOKBCJFDN-UHFFFAOYSA-N 0.000 description 1
CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
239000008116 calcium stearate Substances 0.000 description 1
235000013539 calcium stearate Nutrition 0.000 description 1
239000005018 casein Substances 0.000 description 1
BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
235000021240 caseins Nutrition 0.000 description 1
239000007795 chemical reaction product Substances 0.000 description 1
230000035606 childbirth Effects 0.000 description 1
229960005091 chloramphenicol Drugs 0.000 description 1
WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
208000019902 chronic diarrheal disease Diseases 0.000 description 1
229960002227 clindamycin Drugs 0.000 description 1
KDLRVYVGXIQJDK-AWPVFWJPSA-N clindamycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 KDLRVYVGXIQJDK-AWPVFWJPSA-N 0.000 description 1
230000015271 coagulation Effects 0.000 description 1
238000005345 coagulation Methods 0.000 description 1
239000011248 coating agent Substances 0.000 description 1
238000000576 coating method Methods 0.000 description 1
239000008119 colloidal silica Substances 0.000 description 1
210000001072 colon Anatomy 0.000 description 1
239000003086 colorant Substances 0.000 description 1
230000002860 competitive effect Effects 0.000 description 1
150000001875 compounds Chemical class 0.000 description 1
238000007906 compression Methods 0.000 description 1
230000006835 compression Effects 0.000 description 1
238000013270 controlled release Methods 0.000 description 1
238000007796 conventional method Methods 0.000 description 1
238000010411 cooking Methods 0.000 description 1
208000029078 coronary artery disease Diseases 0.000 description 1
210000004748 cultured cell Anatomy 0.000 description 1
230000034994 death Effects 0.000 description 1
238000010908 decantation Methods 0.000 description 1
206010061428 decreased appetite Diseases 0.000 description 1
238000011161 development Methods 0.000 description 1
230000018109 developmental process Effects 0.000 description 1
235000001434 dietary modification Nutrition 0.000 description 1
235000015872 dietary supplement Nutrition 0.000 description 1
230000029087 digestion Effects 0.000 description 1
239000003085 diluting agent Substances 0.000 description 1
ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
235000019797 dipotassium phosphate Nutrition 0.000 description 1
229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
231100000676 disease causative agent Toxicity 0.000 description 1
208000019258 ear infection Diseases 0.000 description 1
239000003995 emulsifying agent Substances 0.000 description 1
238000005538 encapsulation Methods 0.000 description 1
239000003623 enhancer Substances 0.000 description 1
208000010227 enterocolitis Diseases 0.000 description 1
230000002327 eosinophilic effect Effects 0.000 description 1
238000001125 extrusion Methods 0.000 description 1
235000019197 fats Nutrition 0.000 description 1
230000002349 favourable effect Effects 0.000 description 1
230000004761 fibrosis Effects 0.000 description 1
238000009501 film coating Methods 0.000 description 1
239000007888 film coating Substances 0.000 description 1
235000013312 flour Nutrition 0.000 description 1
235000012631 food intake Nutrition 0.000 description 1
FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 description 1
229940107187 fructooligosaccharide Drugs 0.000 description 1
WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
230000027119 gastric acid secretion Effects 0.000 description 1
239000008273 gelatin Substances 0.000 description 1
229920000159 gelatin Polymers 0.000 description 1
235000019322 gelatine Nutrition 0.000 description 1
235000011852 gelatine desserts Nutrition 0.000 description 1
235000011868 grain product Nutrition 0.000 description 1
238000005469 granulation Methods 0.000 description 1
230000003179 granulation Effects 0.000 description 1
244000005709 gut microbiome Species 0.000 description 1
239000007902 hard capsule Substances 0.000 description 1
239000001257 hydrogen Substances 0.000 description 1
229910052739 hydrogen Inorganic materials 0.000 description 1
150000002431 hydrogen Chemical class 0.000 description 1
238000007654 immersion Methods 0.000 description 1
210000002865 immune cell Anatomy 0.000 description 1
230000007813 immunodeficiency Effects 0.000 description 1
239000003018 immunosuppressive agent Substances 0.000 description 1
230000006872 improvement Effects 0.000 description 1
238000000338 in vitro Methods 0.000 description 1
230000028709 inflammatory response Effects 0.000 description 1
208000014674 injury Diseases 0.000 description 1
239000002054 inoculum Substances 0.000 description 1
238000007689 inspection Methods 0.000 description 1
210000005027 intestinal barrier Anatomy 0.000 description 1
201000009019 intestinal benign neoplasm Diseases 0.000 description 1
210000004347 intestinal mucosa Anatomy 0.000 description 1
230000004673 intestinal mucosal barrier function Effects 0.000 description 1
208000003243 intestinal obstruction Diseases 0.000 description 1
208000002551 irritable bowel syndrome Diseases 0.000 description 1
208000028867 ischemia Diseases 0.000 description 1
208000017169 kidney disease Diseases 0.000 description 1
201000006370 kidney failure Diseases 0.000 description 1
238000004898 kneading Methods 0.000 description 1
230000006651 lactation Effects 0.000 description 1
238000002386 leaching Methods 0.000 description 1
TYZROVQLWOKYKF-ZDUSSCGKSA-N linezolid Chemical compound O=C1O[C@@H](CNC(=O)C)CN1C(C=C1F)=CC=C1N1CCOCC1 TYZROVQLWOKYKF-ZDUSSCGKSA-N 0.000 description 1
229960003907 linezolid Drugs 0.000 description 1
150000002632 lipids Chemical class 0.000 description 1
238000009630 liquid culture Methods 0.000 description 1
210000004185 liver Anatomy 0.000 description 1
238000012153 long-term therapy Methods 0.000 description 1
239000000314 lubricant Substances 0.000 description 1
210000003563 lymphoid tissue Anatomy 0.000 description 1
229910052919 magnesium silicate Inorganic materials 0.000 description 1
235000019792 magnesium silicate Nutrition 0.000 description 1
229910000386 magnesium trisilicate Inorganic materials 0.000 description 1
235000019793 magnesium trisilicate Nutrition 0.000 description 1
229940099273 magnesium trisilicate Drugs 0.000 description 1
235000009973 maize Nutrition 0.000 description 1
229910000357 manganese(II) sulfate Inorganic materials 0.000 description 1
239000011159 matrix material Substances 0.000 description 1
235000012054 meals Nutrition 0.000 description 1
230000003340 mental effect Effects 0.000 description 1
230000004060 metabolic process Effects 0.000 description 1
206010061289 metastatic neoplasm Diseases 0.000 description 1
230000004899 motility Effects 0.000 description 1
210000000214 mouth Anatomy 0.000 description 1
239000006872 mrs medium Substances 0.000 description 1
201000006417 multiple sclerosis Diseases 0.000 description 1
210000000653 nervous system Anatomy 0.000 description 1
235000015097 nutrients Nutrition 0.000 description 1
208000030212 nutrition disease Diseases 0.000 description 1
229940127249 oral antibiotic Drugs 0.000 description 1
LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 description 1
235000019629 palatability Nutrition 0.000 description 1
244000045947 parasite Species 0.000 description 1
230000002093 peripheral effect Effects 0.000 description 1
230000002085 persistent effect Effects 0.000 description 1
229920001223 polyethylene glycol Polymers 0.000 description 1
229920001451 polypropylene glycol Polymers 0.000 description 1
229920001296 polysiloxane Polymers 0.000 description 1
230000008092 positive effect Effects 0.000 description 1
230000035935 pregnancy Effects 0.000 description 1
230000003449 preventive effect Effects 0.000 description 1
208000037920 primary disease Diseases 0.000 description 1
238000012545 processing Methods 0.000 description 1
235000020122 reconstituted milk Nutrition 0.000 description 1
208000023504 respiratory system disease Diseases 0.000 description 1
206010039073 rheumatoid arthritis Diseases 0.000 description 1
JQXXHWHPUNPDRT-WLSIYKJHSA-N rifampicin Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC=2C(O)=C3C([O-])=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N1CC[NH+](C)CC1 JQXXHWHPUNPDRT-WLSIYKJHSA-N 0.000 description 1
229960001225 rifampicin Drugs 0.000 description 1
208000037921 secondary disease Diseases 0.000 description 1
238000000926 separation method Methods 0.000 description 1
238000012163 sequencing technique Methods 0.000 description 1
239000000377 silicon dioxide Substances 0.000 description 1
239000002210 silicon-based material Substances 0.000 description 1
208000017520 skin disease Diseases 0.000 description 1
206010040872 skin infection Diseases 0.000 description 1
230000007142 small intestinal bacterial overgrowth Effects 0.000 description 1
239000011734 sodium Substances 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
235000017281 sodium acetate Nutrition 0.000 description 1
229940087562 sodium acetate trihydrate Drugs 0.000 description 1
239000011780 sodium chloride Substances 0.000 description 1
239000007901 soft capsule Substances 0.000 description 1
235000021055 solid food Nutrition 0.000 description 1
235000014347 soups Nutrition 0.000 description 1
239000004455 soybean meal Substances 0.000 description 1
238000001228 spectrum Methods 0.000 description 1
UQZIYBXSHAGNOE-XNSRJBNMSA-N stachyose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@@H]3[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O3)O)O2)O)O1 UQZIYBXSHAGNOE-XNSRJBNMSA-N 0.000 description 1
230000004936 stimulating effect Effects 0.000 description 1
210000002784 stomach Anatomy 0.000 description 1
239000000126 substance Substances 0.000 description 1
239000005720 sucrose Substances 0.000 description 1
239000013589 supplement Substances 0.000 description 1
238000001356 surgical procedure Methods 0.000 description 1
239000000375 suspending agent Substances 0.000 description 1
230000009885 systemic effect Effects 0.000 description 1
239000000454 talc Substances 0.000 description 1
229910052623 talc Inorganic materials 0.000 description 1
235000012222 talc Nutrition 0.000 description 1
235000010491 tara gum Nutrition 0.000 description 1
239000000213 tara gum Substances 0.000 description 1
229960002180 tetracycline Drugs 0.000 description 1
229930101283 tetracycline Natural products 0.000 description 1
235000019364 tetracycline Nutrition 0.000 description 1
150000003522 tetracyclines Chemical class 0.000 description 1
230000003868 tissue accumulation Effects 0.000 description 1
238000012549 training Methods 0.000 description 1
238000012546 transfer Methods 0.000 description 1
230000009466 transformation Effects 0.000 description 1
230000008733 trauma Effects 0.000 description 1
YWYZEGXAUVWDED-UHFFFAOYSA-N triammonium citrate Chemical compound [NH4+].[NH4+].[NH4+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O YWYZEGXAUVWDED-UHFFFAOYSA-N 0.000 description 1
239000001393 triammonium citrate Substances 0.000 description 1
235000011046 triammonium citrate Nutrition 0.000 description 1
235000013337 tricalcium citrate Nutrition 0.000 description 1
IEDVJHCEMCRBQM-UHFFFAOYSA-N trimethoprim Chemical compound COC1=C(OC)C(OC)=CC(CC=2C(=NC(N)=NC=2)N)=C1 IEDVJHCEMCRBQM-UHFFFAOYSA-N 0.000 description 1
229960001082 trimethoprim Drugs 0.000 description 1
208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
231100000397 ulcer Toxicity 0.000 description 1
208000019206 urinary tract infection Diseases 0.000 description 1
229960003165 vancomycin Drugs 0.000 description 1
MYPYJXKWCTUITO-UHFFFAOYSA-N vancomycin Natural products O1C(C(=C2)Cl)=CC=C2C(O)C(C(NC(C2=CC(O)=CC(O)=C2C=2C(O)=CC=C3C=2)C(O)=O)=O)NC(=O)C3NC(=O)C2NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CC(C)C)NC)C(O)C(C=C3Cl)=CC=C3OC3=CC2=CC1=C3OC1OC(CO)C(O)C(O)C1OC1CC(C)(N)C(O)C(C)O1 MYPYJXKWCTUITO-UHFFFAOYSA-N 0.000 description 1
MYPYJXKWCTUITO-LYRMYLQWSA-O vancomycin(1+) Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C([O-])=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)[NH2+]C)[C@H]1C[C@](C)([NH3+])[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-O 0.000 description 1
230000035899 viability Effects 0.000 description 1
230000009385 viral infection Effects 0.000 description 1
229940088594 vitamin Drugs 0.000 description 1
235000013343 vitamin Nutrition 0.000 description 1
229930003231 vitamin Natural products 0.000 description 1
239000011782 vitamin Substances 0.000 description 1
235000019154 vitamin C Nutrition 0.000 description 1
239000011718 vitamin C Substances 0.000 description 1
235000019165 vitamin E Nutrition 0.000 description 1
229940046009 vitamin E Drugs 0.000 description 1
239000011709 vitamin E Substances 0.000 description 1
238000005406 washing Methods 0.000 description 1
230000037221 weight management Effects 0.000 description 1
239000000080 wetting agent Substances 0.000 description 1
235000008939 whole milk Nutrition 0.000 description 1
230000029663 wound healing Effects 0.000 description 1
235000013618 yogurt Nutrition 0.000 description 1
239000011701 zinc Substances 0.000 description 1
229910052725 zinc Inorganic materials 0.000 description 1
OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
- A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/20—Inorganic substances, e.g. oligoelements
- A23K20/24—Compounds of alkaline earth metals, e.g. magnesium
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Polymers & Plastics (AREA)
Engineering & Computer Science (AREA)
Microbiology (AREA)
Animal Husbandry (AREA)
Zoology (AREA)
Food Science & Technology (AREA)
Molecular Biology (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Mycology (AREA)
Epidemiology (AREA)
Birds (AREA)
Biochemistry (AREA)
Physiology (AREA)
Biotechnology (AREA)
Biomedical Technology (AREA)
Inorganic Chemistry (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Fodder In General (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

FI20095836A 2009-08-12 2009-08-12 Probioottinen valmiste koiran maha- ja suolistokanavassa ilmenevien häiriöiden ennaltaehkäisemiseksi tai hoitamiseksi FI122247B (fi)

Priority Applications (13)

Application Number	Priority Date	Filing Date	Title
FI20095836A FI122247B (fi)	2009-08-12	2009-08-12	Probioottinen valmiste koiran maha- ja suolistokanavassa ilmenevien häiriöiden ennaltaehkäisemiseksi tai hoitamiseksi
SI201031960T SI2464362T1 (sl)	2009-08-12	2010-06-23	Probiotični pripravek za preprečevanje ali zdravljenje pasjih gastrointestinalnih motenj
LTEP10808015.1T LT2464362T (lt)	2009-08-12	2010-06-23	Probiotikų preparatas, skirtas šunų virškinamojo trakto sutrikimų prevencijai arba gydymui
EP10808015.1A EP2464362B1 (en)	2009-08-12	2010-06-23	Probiotic preparation for the prevention or treatment of canine gastrointestinal disorders
DK10808015T DK2464362T3 (da)	2009-08-12	2010-06-23	Probiotisk præparat til forebyggelse eller behandling af mavetarmlidelser hos hunde
US13/389,948 US9095160B2 (en)	2009-08-12	2010-06-23	Probiotic preparation for the prevention or treatment of canine gastrointestinal disorders
HUE10808015A HUE046610T2 (hu)	2009-08-12	2010-06-23	Probiotikus készítmény kutyák gyomor-bélrendszeri rendellenességeinek megelõzésére vagy kezelésére
PCT/FI2010/050538 WO2011018547A1 (en)	2009-08-12	2010-06-23	Probiotic preparation for the prevention or treatment of canine gastrointestinal disorders
CA2770625A CA2770625C (en)	2009-08-12	2010-06-23	Probiotic preparation for the prevention or treatment of canine gastrointestinal disorders
PT108080151T PT2464362T (pt)	2009-08-12	2010-06-23	Preparação probiótica para a prevenção ou o tratamento de distúrbios gastrointestinais caninos
HRP20192223TT HRP20192223T1 (hr)	2009-08-12	2010-06-23	Probiotski pripravak za prevenciju i liječenje psećih probavnih poremećaja
ES10808015T ES2759776T3 (es)	2009-08-12	2010-06-23	Preparación probiótica para la prevención o el tratamiento de trastornos gastrointestinales caninos
PL10808015T PL2464362T3 (pl)	2009-08-12	2010-06-23	Probiotyczny preparat do zapobiegania lub leczenia psich zaburzeń układu pokarmowego

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FI20095836		2009-08-12
FI20095836A FI122247B (fi)	2009-08-12	2009-08-12	Probioottinen valmiste koiran maha- ja suolistokanavassa ilmenevien häiriöiden ennaltaehkäisemiseksi tai hoitamiseksi

Publications (3)

Publication Number	Publication Date
FI20095836A0 FI20095836A0 (fi)	2009-08-12
FI20095836L FI20095836L (fi)	2011-02-13
FI122247B true FI122247B (fi)	2011-10-31

Family

ID=41050665

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI20095836A FI122247B (fi)	2009-08-12	2009-08-12	Probioottinen valmiste koiran maha- ja suolistokanavassa ilmenevien häiriöiden ennaltaehkäisemiseksi tai hoitamiseksi

Country Status (13)

Country	Link
US (1)	US9095160B2 (da)
EP (1)	EP2464362B1 (da)
CA (1)	CA2770625C (da)
DK (1)	DK2464362T3 (da)
ES (1)	ES2759776T3 (da)
FI (1)	FI122247B (da)
HR (1)	HRP20192223T1 (da)
HU (1)	HUE046610T2 (da)
LT (1)	LT2464362T (da)
PL (1)	PL2464362T3 (da)
PT (1)	PT2464362T (da)
SI (1)	SI2464362T1 (da)
WO (1)	WO2011018547A1 (da)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20120321703A1 (en) *	2011-06-16	2012-12-20	Daniel Kouri	Capsule for oral pet medicine
US10130665B2 (en) *	2012-05-18	2018-11-20	Genome Research Limited	Method for identifying bacteria for bacteriotherapy
CN102716381B (zh) *	2012-07-06	2014-02-19	许瑞琴	一种用于治疗阑尾炎的中药
ITMI20121328A1 (it) *	2012-07-30	2014-01-31	Probiotical Spa	Composizione per dispositivo medico comprendente ceppi di batteri produttori di esopolisaccaridi in associazione con gomme e/o gelatine.
WO2014141265A1 (en) *	2013-03-14	2014-09-18	Nofar Gil	Inhibition of neurodegenerative disease by grape seed extract, green tea extract and probiotic bacteria
US20160279181A1 (en) *	2013-11-07	2016-09-29	Suntory Holdings Limited	Intestinal barrier function enhancer containing lactic acid bacteria
DE102014103832A1 (de) *	2014-02-13	2015-08-13	Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh	Zusammensetzung zur Behandlung von Magenbeschwerden
WO2015135470A1 (zh)	2014-03-13	2015-09-17	曾忠铭	一种阴道用组合物与该组合物的用途
CN104611275B (zh) *	2015-02-11	2017-10-17	成都与康科技有限公司	植物乳杆菌ucn‑11菌株及其组合物和应用
EP3831391A1 (en)	2015-09-29	2021-06-09	Kimberly-Clark Worldwide, Inc.	Composition for maintaining lactobacillus dominance with isomaltulose
CN108235682A (zh) *	2015-09-29	2018-06-29	金伯利-克拉克环球有限公司	用于维护微生物群落的健康平衡的协同组合物
US9855305B2 (en)	2016-03-29	2018-01-02	Companion Therapeutics Llc	Pharmaceutical composition containing combinations of vitamins, minerals, probiotics, and prebiotics effective in preventing adverse effects associated with the use of proton-pump inhibitors
CN108236043A (zh) *	2016-12-23	2018-07-03	高鹏	一种含水苏糖的合生元饲料添加剂
HUE065794T2 (hu) *	2017-01-19	2024-06-28	Int N&H Denmark Aps	Szárított mikroorganizmus segédanyaggal
WO2018134135A1 (en) *	2017-01-19	2018-07-26	Dupont Nutrition Biosciences Aps	Dried microorganism with excipient
KR102769558B1 (ko)	2017-02-28	2025-02-19	킴벌리-클라크 월드와이드, 인크.	미생물총의 건강한 균형을 유지하기 위한 상승적 조성물
KR102250597B1 (ko) *	2017-11-20	2021-05-11	경희대학교 산학협력단	신규 유산균 및 이의 용도
GB201719480D0 (en) *	2017-11-23	2018-01-10	Optibiotix Ltd	Compositions
CN107912589A (zh) *	2017-12-21	2018-04-17	广州莱可福生物科技有限公司	含益生菌且可改善肠道和免疫力的压片糖果及其制备方法
CN108323761A (zh) *	2017-12-27	2018-07-27	深圳市麦金利实业有限公司	一种复合活性益生菌制剂及其制备方法
FI128916B (en) *	2018-02-05	2021-03-15	Vetcare Oy	Health-promoting composition and method for its preparation
US11666614B2 (en) *	2018-08-21	2023-06-06	Canbiocin Inc.	Probiotic bacteria isolated from wolves and related compositions and methods
CN109430522A (zh) *	2018-10-22	2019-03-08	重庆布尔动物药业有限公司	一种犬用抗应激益生菌制剂及其制备方法
CN120249516A (zh)	2019-01-23	2025-07-04	马斯公司	肠道微生物或胆汁酸在制备确定动物肠道疾病易感性、对饮食的反应性、有效性的制剂或治疗狗肠道疾病的药物中的用途、饮食及试剂盒
CN110193030A (zh) *	2019-04-29	2019-09-03	山东苏柯汉生物工程股份有限公司	一种犬用微生态制剂及其制备方法
CN111202164B (zh) *	2019-06-13	2023-10-13	杭州海渤源生物科技有限公司	一种宠物驱虫复合软胶囊及其制备方法
US20230248788A1 (en) *	2020-06-29	2023-08-10	Canbiocin Inc.	Compositions and related methods for supporting companion animals with gastrointestinal disorders
CN112176005B (zh) *	2020-10-27	2022-04-29	清远一生自然生物研究院有限公司	一种丙酸钙的生产方法
CN112273533A (zh) *	2020-10-28	2021-01-29	广州福懋畜牧兽医服务有限公司	一种用于肠道护理的犬粮及其制备方法
CN113388546B (zh) *	2021-06-21	2022-04-12	齐鲁工业大学	一种复合微生态制剂及其在提高肠道短链脂肪酸中的应用
CN113841900A (zh) *	2021-09-09	2021-12-28	绵阳市润土农业科技开发有限公司	一种体内发酵产物的制备方法及在预防慢病方面的应用
CN113637615B (zh) *	2021-09-28	2022-03-08	上海信元宠物食品有限公司	一种融合魏斯氏菌、培养方法及其应用
CN113832085B (zh) *	2021-11-29	2022-02-11	北京量化健康科技有限公司	戊糖乳杆菌bnpv及其应用
CN115381871B (zh) *	2022-08-25	2024-03-22	郑州大学	一种果胶低聚糖益生菌复合物软胶囊及制备方法和应用
CN115969957B (zh) *	2022-12-21	2023-07-11	浙江佰穗莱生命健康科技有限公司	一种炎性肠病复合益生菌制剂及其制备方法
CN117598393A (zh) *	2023-10-09	2024-02-27	云南农业大学	一种警犬专用复合微生态制剂及其在昆明犬幼犬养殖中的应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS63209580A (ja)	1987-02-25	1988-08-31	Karupisu Shokuhin Kogyo Kk	バチルス・ズブチリスｃ−３１０２
US4806368A (en) *	1987-09-16	1989-02-21	Reddy Malireddy S	Shelf life and subsequent growth of lactobacillus acidophilus, propionibacterium shermanii and leuconostoc citrovorum in dietary fiber based supplement preparation
DE19527617A1 (de) *	1995-07-28	1997-01-30	Basf Ag	Verfahren zur Herstellung eines Kombinationspräparats zum Silieren von Grünfutter
US5876990A (en) *	1996-10-22	1999-03-02	Reddy; Malireddy S.	Biochemical media system for reducing pollution
US5952033A (en)	1996-12-24	1999-09-14	Nestec S.A.	Gelatinized cereal product containing oligosaccharide and processes of preparing and using same
IT1307850B1 (it) *	1999-03-15	2001-11-19	Italmed Di Galli Giovanna E Pa	Composizione farmaceutica a base di fermenti lattici e carboidratinon assorbibili contenente un sale di calcio ed un sale di alluminio
MXPA02002195A (es)	1999-09-09	2002-09-18	Nestle Sa	Mejoramiento del estado de mascotas viejas.
DE60119515T2 (de)	2000-05-25	2007-05-24	Société des Produits Nestlé S.A.	Probiotica für verwendung als haustierfutter
EP1374878A1 (en)	2002-06-20	2004-01-02	N.V. Nutricia	Method and composition for preventing or alleviating symptoms of malabsorption from the gastrointestinal tract
US8894991B2 (en)	2003-12-19	2014-11-25	The Iams Company	Canine probiotic Lactobacilli
US7785635B1 (en) *	2003-12-19	2010-08-31	The Procter & Gamble Company	Methods of use of probiotic lactobacilli for companion animals
US8877178B2 (en)	2003-12-19	2014-11-04	The Iams Company	Methods of use of probiotic bifidobacteria for companion animals
US20060228448A1 (en)	2005-04-11	2006-10-12	The Iams Company	Pet food compositions comprising two components
US7595079B2 (en)	2005-07-08	2009-09-29	Bomac Vets Plus, Inc.	Nutritional conjunctive support therapy for recovery in animals following stress or illness
EP1978821B2 (en)	2005-12-29	2019-02-06	Hill's Pet Nutrition, Inc.	Method for modifying gut flora in animals
US20100316769A1 (en)	2006-03-29	2010-12-16	Gail Czarnecki-Maulden	Dietary supplements containing probiotics
EP2022502A1 (en) *	2007-08-10	2009-02-11	Nestec S.A.	Lactobacillus rhamnosus and weight control

2009
- 2009-08-12 FI FI20095836A patent/FI122247B/fi active IP Right Grant
2010
- 2010-06-23 PT PT108080151T patent/PT2464362T/pt unknown
- 2010-06-23 PL PL10808015T patent/PL2464362T3/pl unknown
- 2010-06-23 ES ES10808015T patent/ES2759776T3/es active Active
- 2010-06-23 CA CA2770625A patent/CA2770625C/en active Active
- 2010-06-23 DK DK10808015T patent/DK2464362T3/da active
- 2010-06-23 SI SI201031960T patent/SI2464362T1/sl unknown
- 2010-06-23 HR HRP20192223TT patent/HRP20192223T1/hr unknown
- 2010-06-23 LT LTEP10808015.1T patent/LT2464362T/lt unknown
- 2010-06-23 US US13/389,948 patent/US9095160B2/en active Active
- 2010-06-23 HU HUE10808015A patent/HUE046610T2/hu unknown
- 2010-06-23 WO PCT/FI2010/050538 patent/WO2011018547A1/en not_active Ceased
- 2010-06-23 EP EP10808015.1A patent/EP2464362B1/en active Active

Also Published As

Publication number	Publication date
DK2464362T3 (da)	2019-12-09
US20120201796A1 (en)	2012-08-09
PT2464362T (pt)	2019-12-16
ES2759776T3 (es)	2020-05-12
CA2770625A1 (en)	2011-02-17
HUE046610T2 (hu)	2020-03-30
PL2464362T3 (pl)	2020-03-31
FI20095836L (fi)	2011-02-13
EP2464362A1 (en)	2012-06-20
EP2464362B1 (en)	2019-09-11
FI20095836A0 (fi)	2009-08-12
US9095160B2 (en)	2015-08-04
CA2770625C (en)	2021-03-23
HRP20192223T1 (hr)	2020-03-06
EP2464362A4 (en)	2015-05-06
WO2011018547A1 (en)	2011-02-17
SI2464362T1 (sl)	2020-02-28
LT2464362T (lt)	2020-01-10

Legal Events

Date

Code

Title

Description